OIMU
GILD icon

Osmosis Investment Management UK’s Gilead Sciences GILD Stock Holding History

Osmosis Investment Management UK’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Sell
90,311
-83,273
-48% -$11M 0.53% 37
2026
Q1 		$24.2M Buy
173,584
+83,241
+92% +$11.7M 0.65% 28
2025
Q4 		$11.1M Buy
+90,343
New +$11M 0.28% 81

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osmosis Investment Management UK's GILD Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Gilead Sciences (GILD) stake by 48% in Q2 2026, selling an estimated $11M and leaving 90,311 shares worth $11.4M. The position accounts for 0.53% of the portfolio, ranked #37.

Osmosis Investment Management UK first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $24.2M in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Osmosis Investment Management UK held 90,311 shares of Gilead Sciences worth $11.4M as of Q2 2026.
  • Osmosis Investment Management UK sold 83,273 Gilead Sciences shares in Q2 2026, an estimated $11M.
  • Gilead Sciences made up 0.53% of Osmosis Investment Management UK's portfolio in Q2 2026, its #37 holding.
  • Osmosis Investment Management UK first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Gilead Sciences position peaked at $24.2M in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.